Jens Buentzel

Summary

Affiliation: Head and Neck Surgery
Country: Germany

Publications

  1. ncbi request reprint Tumor markers and lymphatic metastasis in head and neck cancer patients
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Sudharzkrankenhaus Nordhausen, 99734 Nordhausen, Germany
    Anticancer Res 25:1539-42. 2005
  2. ncbi request reprint Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patients
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Suedharz Krankenhaus, Nordhausen gGmbH, Nordhausen, Germany
    Anticancer Res 30:1783-6. 2010
  3. ncbi request reprint Nutritional parameters for patients with head and neck cancer
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Südharz Hospital, Nordhausen, Germany
    Anticancer Res 32:2119-23. 2012
  4. pmc Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease
    Jan Kriz
    Klinik fur Strahlentherapie und Radioonkologie, Franziskus Hospital, Bielefeld, Germany
    Radiat Oncol 8:233. 2013
  5. pmc Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial
    Ralph Muecke
    Department of Radiotherapy, Lippe Hospital, Lemgo, Germany
    Radiat Oncol 8:72. 2013
  6. ncbi request reprint [Inappropriate and insufficient nutrition in ENT tumors]
    J Buntzel
    Klinik für HNO Krankheiten, Kopf Hals Chirurgie, Südharz Krankenhaus Nordhausen gGmbH, Dr Robert Koch Str 39, 99734, Nordhausen, Deutschland
    HNO 59:1139-47; quiz 1148-9. 2011
  7. ncbi request reprint Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients
    J Buntzel
    Department of Otolaryngology, Head Neck Surgery, Sudharz Krankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 30:1829-32. 2010
  8. ncbi request reprint Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study
    Jens Büntzel
    Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 27:1953-6. 2007
  9. ncbi request reprint Zinc concentrations in serum during head and neck cancer progression
    Jens Büntzel
    Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 27:1941-3. 2007
  10. ncbi request reprint Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study
    Jens Buentzel
    Department of Otolaryngology, Head and Neck Surgery, Suedharzkrankenhaus Nodhausen, Nordhausen, Germany
    Int J Radiat Oncol Biol Phys 64:684-91. 2006

Collaborators

  • Frank Bruns
  • Ulrich Schäfer
  • O Micke
  • J Buntzel
  • Ralph Muecke
  • Jan Kriz
  • Dieter Baaske
  • Berthold Reichl
  • Franz J Prott
  • Lutz Schomburg
  • Reinhard Heyd
  • Guenther Kundt
  • Hans Th Eich
  • Regina Berndt-Skorka
  • Jutta Huebner
  • Michael Glatzel
  • Uwe Haverkamp
  • Heinrich Seegenschmiedt
  • Klaus Kisters
  • Hans Theodor Eich
  • Ulrich Schaefer
  • Irenaeus A Adamietz

Detail Information

Publications11

  1. ncbi request reprint Tumor markers and lymphatic metastasis in head and neck cancer patients
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Sudharzkrankenhaus Nordhausen, 99734 Nordhausen, Germany
    Anticancer Res 25:1539-42. 2005
    ..This study was conducted to evaluate the relationship between the lymph node status and tumor marker status in patients with histologically confirmed head and neck cancer...
  2. ncbi request reprint Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patients
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Suedharz Krankenhaus, Nordhausen gGmbH, Nordhausen, Germany
    Anticancer Res 30:1783-6. 2010
    ..A reduced activity of GSH-Px is related to increased toxicities due to radiation therapy during primary cancer treatment. Therefore, selenium substitution may be a new supportive strategy to diminish radiation-associated side effects...
  3. ncbi request reprint Nutritional parameters for patients with head and neck cancer
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Südharz Hospital, Nordhausen, Germany
    Anticancer Res 32:2119-23. 2012
    ..Determination of the optimal nutritional parameter to provide useful information for the individual patient and assessing the impact of nutritional status have on the prognosis of head and neck cancer...
  4. pmc Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease
    Jan Kriz
    Klinik fur Strahlentherapie und Radioonkologie, Franziskus Hospital, Bielefeld, Germany
    Radiat Oncol 8:233. 2013
    ..Because treatment concepts are not well defined the German Cooperative Group on Radiotherapy for Benign Diseases performed a retrospective analysis...
  5. pmc Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial
    Ralph Muecke
    Department of Radiotherapy, Lippe Hospital, Lemgo, Germany
    Radiat Oncol 8:72. 2013
    ..Now, a potential relation between the planning target volume (PTV) of the RT and the Se effect concerning radiation induced diarrhoea was evaluated in detail...
  6. ncbi request reprint [Inappropriate and insufficient nutrition in ENT tumors]
    J Buntzel
    Klinik für HNO Krankheiten, Kopf Hals Chirurgie, Südharz Krankenhaus Nordhausen gGmbH, Dr Robert Koch Str 39, 99734, Nordhausen, Deutschland
    HNO 59:1139-47; quiz 1148-9. 2011
    ..Partial or total parenteral nutrition (central venous access) should be restricted to crisis interventions or fast-track regimens...
  7. ncbi request reprint Limited effects of selenium substitution in the prevention of radiation-associated toxicities. results of a randomized study in head and neck cancer patients
    J Buntzel
    Department of Otolaryngology, Head Neck Surgery, Sudharz Krankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 30:1829-32. 2010
    ..g. irradiation or chemotherapy, and therefore the objective of this study was to investigate the clinical impact of selenium in such therapies...
  8. ncbi request reprint Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up study
    Jens Büntzel
    Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 27:1953-6. 2007
    ..The late toxicities due to multimodal therapy of advanced head and neck cancers were analysed. The impact of cytoprotection with amifostine is the specific objective of this report...
  9. ncbi request reprint Zinc concentrations in serum during head and neck cancer progression
    Jens Büntzel
    Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
    Anticancer Res 27:1941-3. 2007
    ..Reduced serum-zinc concentrations are well known as typical laboratory characteristics in advanced head and neck cancer. Our aim was to follow the development of this phenomenon during the disease...
  10. ncbi request reprint Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study
    Jens Buentzel
    Department of Otolaryngology, Head and Neck Surgery, Suedharzkrankenhaus Nodhausen, Nordhausen, Germany
    Int J Radiat Oncol Biol Phys 64:684-91. 2006
    ..This randomized, double-blinded, placebo-controlled, phase III study evaluated the efficacy and safety of i.v. amifostine during radiochemotherapy for head-and-neck cancer...
  11. ncbi request reprint Serum selenium in head and neck cancer patients--a new marker of tumor activity?
    Jens Büntzel
    Department of Otolaryngology, Head Neck Surgery, Sudharzkrankenhaus Nordhausen, 99734 Nordhausen, Germany
    Anticancer Res 25:1711-2. 2005
    ..The purpose of this work was to investigate the relationship between the tumor volume and the endogenous selenium levels in untreated head and neck cancer patients...